The pharmacokinetics of Biolimus A9 after elution from the BioMatrix II stent in patients with coronary artery disease: the Stealth PK Study (Q85232794)

From Wikidata

Jump to navigation Jump to search

scientific article published on 09 October 2010

Language	Label	Description	Also known as
English	The pharmacokinetics of Biolimus A9 after elution from the BioMatrix II stent in patients with coronary artery disease: the Stealth PK Study	scientific article published on 09 October 2010

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963405%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

The pharmacokinetics of Biolimus A9 after elution from the BioMatrix II stent in patients with coronary artery disease: the Stealth PK Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963405%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

coronary artery disease

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

Zoran D Perisic

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963405%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

author name string

Miodrag C Ostojic

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963405%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Dragan Sagic

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963405%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Robert Jung

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963405%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Yan-Ling Zhang

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963405%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Jamie Bendrick-Peart

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963405%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Ronald Betts

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963405%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Uwe Christians

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963405%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

Stealth PK Investigators

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963405%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

publication date

9 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963405%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

European Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963405%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

67

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963405%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963405%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

389-398

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20963405%20AND%20SRC:MED&resulttype=core&format=json

15 February 2020

https://scigraph.springernature.com/pub.10.1007/s00228-010-0895-1

0 references

Update on In-stent Restenosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sirolimus: a comprehensive review

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One year results of a new in situ length-adjustable stent platform with a biodegradable biolimus A9 eluting polymer: results of the CUSTOM-II trial.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

9-month clinical, angiographic, and intravascular ultrasound results of a prospective evaluation of the Axxess self-expanding biolimus A9-eluting stent in coronary bifurcation lesions: the DIVERGE (Drug-Eluting Stent Intervention for Treating Side B

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biolimus-eluting biodegradable polymer versus sirolimus-eluting permanent polymer stent performance in long lesions: results from the LEADERS multicentre trial substudy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapamycins: mechanism of action and cellular resistance

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of vessel size on angiographic and clinical outcomes of revascularization with biolimus-eluting stent with biodegradable polymer and sirolimus-eluting stent with durable polymer the LEADERS trial substudy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Automated, fast and sensitive quantification of drugs in blood by liquid chromatography-mass spectrometry with on-line extraction: immunosuppressants

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacokinetics of Biolimus A9 after elution from the Nobori stent in patients with coronary artery disease: the NOBORI PK study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of drug-eluting stents on local endothelium-dependent coronary vasomotion

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and validation of a semi-automated assay for the highly sensitive quantification of Biolimus A9 in human whole blood using high-performance liquid chromatography-tandem mass spectrometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, double-blind, placebo-controlled, single intravenous dose-escalation study to evaluate the safety, tolerability, and pharmacokinetics of the novel coronary smooth muscle cell proliferation inhibitor Biolimus A9 in healthy individuals

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and validation of a high-throughput assay for quantification of the proliferation inhibitor ABT-578 using LC/LC-MS/MS in blood and tissue samples

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BioMatrix Biolimus A9-eluting coronary stent: a next-generation drug-eluting stent for coronary artery disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiographic results of the first human experience with the Biolimus A9 drug-eluting stent for de novo coronary lesions.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Update on drug-eluting coronary stents

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New developments in coronary stent technology

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug-eluting stents: preventing restenosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sirolimus PK trial: a pharmacokinetic study of the sirolimus-eluting Bx velocity stent in patients with de novo coronary lesions

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bifurcation stenting with a dedicated biolimus-eluting stent: X-ray visual enhancement of the final angiographic result with "StentBoost Subtract".

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sirolimus: its discovery, biological properties, and mechanism of action

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics of everolimus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coronary in-stent restenosis: current status and future strategies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacokinetics of sirolimus

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Novel drug eluting stent system for customised treatment of coronary lesions: CUSTOM I feasibility trial 24 month results

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An update on clinical and pharmacological aspects of drug-eluting stents

1 reference

https://pubmed.ncbi.nlm.nih.gov/20963405

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85232794&oldid=2143595816"